Literature DB >> 8861831

Psychotropic drug use in a group of Dutch nursing home patients with dementia: many users, long-term use, but low doses.

R T Koopmans1, J M van Rossum, H J van den Hoogen, Y A Hekster, M A Willekens-Bogaers, C van Weel.   

Abstract

The aim of this study was to describe the use of psychotropic drugs in a psychogeriatric nursing home, "Joachim en Anna", in Nijmegen, the Netherlands. To this end the medical records of 890 nursing home patients with dementia, admitted between 1980 and 1989, were analysed retrospectively. Each time pattern of psychotropic drug use was registered. Drugs were coded by means of the Anatomical Therapeutic Chemical classification system. The daily dose was expressed as the ratio of the mean prescribed daily dose and the defined daily dose. Side-effects and changes in prescription patterns throughout the years patients were admitted were analysed. A total of 3,090 time patterns of exposure to psychotropics were registered. Neuroleptics, benzodiazepines, and antidepressants accounted for 58, 32, and 9 percent of the time patterns, respectively. For almost every drug prescription the prescribed daily dose was lower than the defined daily dose. More than 75 percent of these nursing home patients had at least one prescription for a psychotropic drug during institutionalization. One or more side-effects were observed in 50 percent of the patients who used a neuroleptic. The total number of patients receiving psychotropics did not change throughout the study. Psychotropics were prescribed for long-term use, but in a low dose. Side-effects were frequently observed while the correct individual dose was being determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861831     DOI: 10.1007/bf00449689

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  22 in total

Review 1.  Psychosis, behavioral disturbance, and the use of neuroleptics in dementia.

Authors:  D P Devanand; H A Sackeim; R Mayeux
Journal:  Compr Psychiatry       Date:  1988 Jul-Aug       Impact factor: 3.735

2.  Remediable behavioral symptomatology in Alzheimer's disease.

Authors:  B Reisberg; J Borenstein; E Franssen; E Shulman; G Steinberg; S H Ferris
Journal:  Hosp Community Psychiatry       Date:  1986-12

3.  [Neuroleptics in psychogeriatrics. A proposal for a more rational prescription policy].

Authors:  M A Willekens-Bogaers; E J Vollaard
Journal:  Tijdschr Gerontol Geriatr       Date:  1985-10

4.  The use and misuse of psychotropic prescribing for elderly psychiatric patients.

Authors:  R J Ancill; G D Embury; G W MacEwan; J S Kennedy
Journal:  Can J Psychiatry       Date:  1988-10       Impact factor: 4.356

Review 5.  Variability in patterns of drug usage.

Authors:  H G Leufkens; J Urquhart
Journal:  J Pharm Pharmacol       Date:  1994-05       Impact factor: 3.765

Review 6.  Monitoring progression in Alzheimer's disease.

Authors:  D Galasko; J Corey-Bloom; L J Thal
Journal:  J Am Geriatr Soc       Date:  1991-09       Impact factor: 5.562

7.  A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies.

Authors:  T P van Staa; L Abenhaim; H Leufkens
Journal:  J Clin Epidemiol       Date:  1994-02       Impact factor: 6.437

Review 8.  Pharmacologic treatment of agitation associated with dementia.

Authors:  S C Risse; R Barnes
Journal:  J Am Geriatr Soc       Date:  1986-05       Impact factor: 5.562

9.  [Reduction of drug intake following admission to a psychogeriatric nursing home: discontinuation is possible].

Authors:  R T Koopmans; H H de Vaan; H J van den Hoogen; F W Gribnau; Y A Hekster; C van Wheel
Journal:  Ned Tijdschr Geneeskd       Date:  1993-05-22

10.  [Changes in drug use during a stay in a psychogeriatric nursing home].

Authors:  R T Koopmans; H H de Vaan; H J van den Hoogen; F W Gribnau; Y A Hekster; C van Weel
Journal:  Ned Tijdschr Geneeskd       Date:  1994-05-28
View more
  1 in total

1.  Does organisational culture influence prescribing in care homes for older people? A new direction for research.

Authors:  Carmel M Hughes; Kate Lapane; Margaret C Watson; Huw T O Davies
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.